Pulse Biosciences, Inc.
(NASDAQ : PLSE)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
MDTMedtronic PLC
1.07%83.220.6%$511.74m
TMOThermo Fisher Scientific Inc.
0.37%193.461.0%$313.18m
ALGNAlign Technology, Inc.
0.34%255.246.3%$300.91m
BDXBecton, Dickinson and Company
0.35%225.011.3%$291.93m
ABTAbbott Laboratories
0.25%55.940.8%$289.74m
ISRGIntuitive Surgical, Inc.
0.38%398.112.5%$269.48m
BSXBoston Scientific Corporation
0.28%28.551.1%$202.61m
EWEdwards Lifesciences Corporation
-0.31%108.471.2%$198.36m
SYKStryker Corporation
-0.10%154.641.3%$185.45m
ZBHZimmer Biomet Holdings, Inc.
-0.24%112.801.7%$168.06m
BCRC. R. Bard, Inc.
0.06%335.371.6%$161.94m
BAXBaxter International Inc.
0.22%64.181.7%$159.43m
XRAYDENTSPLY International Inc.
-0.24%67.433.0%$132.47m
HOLXHologic, Inc.
-0.05%40.861.7%$131.89m
IDXXIDEXX Laboratories, Inc.
0.36%154.623.7%$96.34m

Company Profile

Pulse Biosciences, Inc. is a development stage medical device company. It manufactures surgical and medical instruments uses a novel and proprietary platform technology called Nano-Pulse Electro-Signaling. The NPES provides local tumor control and initiates an adaptive immune response with a vaccine-like effect by inducing immunogenic apoptosis of the cells. The company was founded on May 19, 2014 and is headquartered in Burlingame, CA.